APOLLOHOSP - Apollo Hospitals Enterprise Limited
NSE
->
Healthcare
->
Medical Care Facilities
Chennai,
India
Type: Equity
APOLLOHOSP price evolution
APOLLOHOSP
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $10027.1 | $5830 | ||
| Short term investments | $3245.2 | |||
| Net receivables | $22473.5 | $19497 | ||
| Inventory | $4365 | $4319 | ||
| Total current assets | $43534.5 | $41216 | ||
| Long term investments | $3061.3 | $2783 | ||
| Property, plant & equipment | $77565.8 | $72789 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $139748.4 | $131924 | ||
| Current liabilities | ||||
| Accounts payable | $21199.1 | $16318 | ||
| Deferred revenue | ||||
| Short long term debt | $2490.3 | $1988 | ||
| Total current liabilities | $29627.1 | $23833 | ||
| Long term debt | $23107.9 | $24272 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $76824.3 | $73147 | ||
| Shareholders' equity | ||||
| Retained earnings | $27949 | |||
| Other shareholder equity | $59209.8 | -$1072 | ||
| Total shareholder equity | $59928.7 | $56233 | $56233 | $53046.7 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5830 | $4252 | $3807 | $2862 |
| Short term investments | ||||
| Net receivables | $19497 | $14889 | $11928 | $11458 |
| Inventory | $4319 | $2495 | $7378 | $5848 |
| Total current assets | $41216 | $36413 | $26469 | $22817 |
| Long term investments | $2783 | $3449 | $3592 | $3928 |
| Property, plant & equipment | $72789 | $65457 | $72609 | $54156 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $131924 | $114167 | $113384 | $91831 |
| Current liabilities | ||||
| Accounts payable | $16318 | $11600 | $9088 | $7131 |
| Deferred revenue | ||||
| Short long term debt | $1988 | $3675 | $2460 | $2210 |
| Total current liabilities | $23833 | $20378 | $23373 | $19554 |
| Long term debt | $24272 | $24734 | $28520 | $29514 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $73147 | $66143 | $78687 | $57141 |
| Shareholders' equity | ||||
| Retained earnings | $27949 | $17179 | $15513 | $14954 |
| Other shareholder equity | -$1072 | -$510 | $42 | $546 |
| Total shareholder equity | $56233 | $46025 | $33390 | $33335 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $42510.7 | $40233.35 | $35464 | $36389.3 |
| Cost of revenue | $27127 | $25561.2 | $24339.9 | $22631.3 |
| Gross Profit | $15383.7 | $14672.15 | $11124.1 | $13758 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4669 | $4669 | ||
| Total operating expenses | $38407.1 | $36466.75 | $32455.9 | $32009 |
| Operating income | $4103.6 | $3766.6 | $3008.1 | $4380.3 |
| Income from continuing operations | ||||
| EBIT | $4103.6 | $3766.6 | $3008.1 | $4380.3 |
| Income tax expense | $1142.3 | $223.65 | $1386.5 | $1242.2 |
| Interest expense | -$927 | -$927.1 | -$466.6 | -$936.7 |
| Net income | ||||
| Net income | $2039.9 | $2605.5 | $901.3 | $2283.7 |
| Income (for common shares) | $2039.9 | $2605.5 | $901.3 | $2283.7 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $146626 | $105600 | $112468 | $96175 |
| Cost of revenue | $95317 | $74204 | $74796 | $63598 |
| Gross Profit | $51309 | $31396 | $37672 | $32577 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4669 | $2635 | $3348 | $5476 |
| Total operating expenses | $130742 | $99928 | $102755 | $89433 |
| Operating income | $15884 | $5672 | $9713 | $6742 |
| Income from continuing operations | ||||
| EBIT | $15884 | $5672 | $9713 | $6742 |
| Income tax expense | $4770 | $847 | $2252 | $1734 |
| Interest expense | -$3304 | -$4058 | -$4633 | -$2837 |
| Net income | ||||
| Net income | $10556 | $1504 | $4549 | $2360 |
| Income (for common shares) | $10556 | $1504 | $4549 | $2360 |
| (in millions $) | 29 Sep 2022 | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 |
|---|---|---|---|---|
| Net income | $2039.9 | $2605.5 | $901.3 | $2283.7 |
| Operating activities | ||||
| Depreciation | $1513.95 | $1513.95 | $1513.95 | $1513.95 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $4967.05 | $4967.05 | $4967.05 | $4967.05 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$2798.7 | -$2798.7 | -$2798.7 | -$2798.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2273.55 | -$2273.55 | -$2273.55 | -$2273.55 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$105.2 | -$105.2 | -$105.2 | -$105.2 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $10556 | $1504 | $4549 | $2360 |
| Operating activities | ||||
| Depreciation | $5606 | $5506 | $5944 | $3766 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $16280 | $12647 | $12929 | $9052 |
| Investing activities | ||||
| Capital expenditures | -$6572 | -$2955 | -$5130 | -$6789 |
| Investments | -$733 | -$11356 | $2043 | -$534 |
| Total cash flows from investing | -$7782 | -$8634 | -$2888 | -$7106 |
| Financing activities | ||||
| Dividends paid | -$433 | -$383 | -$1287 | -$837 |
| Sale and purchase of stock | ||||
| Net borrowings | -$3719 | -$9858 | -$1860 | $2348 |
| Total cash flows from financing | -$7926 | -$3401 | -$9095 | -$2147 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1578 | $446 | $945 | -$201 |
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $154.60B |
|---|---|
| EBITDA | $21.31B |
| EBIT | $15.26B |
| Net Income | $7.83B |
| Revenue Q/Q | 14.37% |
| Revenue Y/Y | 17.97% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | 13.89% |
| Debt/Equity | 1.30 |
|---|---|
| Net debt/EBITDA | 3.13 |
| Current ratio | 1.47 |
| Quick ratio | 1.32 |